Key terms
About ZNTL/
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in New York, NY.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ZNTL/ news
No recent TipRanks articles are available for ZNTL/
No recent press releases are available for ZNTL/
ZNTL/ Financials
Key terms
Ad Feedback
ZNTL/ Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ZNTL/ Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
